Replies to post #12974 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

BAX can: a) defer the deadline to make a decision by paying $5M per drug ($20M for four drugs); or b) pay $28M to exercise the option and license up to four additional drugs (#msg-96383250).

I doubt that BAX will choose a).